ABSTRACT
INTRODUCTION: We conducted an all-case postmarketing surveillance study between 2008 and 2017 to evaluate the safety and effectiveness of risedronate for Paget's disease of bone (PDB) in Japan. MATERIAL AND METHODS: This study registered all patients who received once-daily risedronate 17.5 mg for the treatment of PDB and collected data over a 48-week follow-up period per treatment cycle for each patient. RESULTS: The safety analysis set included 184 patients (mean age, 63.7 years), 81 (44.0%) of whom previously received a bisphosphonate. Of them, 41 (22.3%) experienced 72 adverse drug reactions (ADRs), and 8 (4.3%) experienced 14 serious ADRs. Common ADRs included gastrointestinal disorders (20 patients, 10.9%) and hypocalcemia (6 patients, 3.3%). The effectiveness analysis set included 182 patients, 124 of whom completed only one treatment cycle and 58 of whom completed multiple treatment cycles. The proportions of patients who normalized serum alkaline phosphatase (ALP) concentration were 71.1% (113/159 patients) and 67.3% (33/49 patients) for the first and second treatment cycles, respectively. The relapse rate according to ALP levels after the end of treatment for the first cycle was 5.0% (95% confidence interval [CI] = 2.1-11.5) at 24 weeks and 12.9% (95% CI = 7.5-21.7) at 40 weeks. Regarding pain relief, the achievement rates were 70.0% (49/70 patients) and 30.8% (4/13 patients) for the first and second treatment cycles, respectively. CONCLUSION: To conclude, risedronate 17.5 mg/day is safe and effective for treating patients with PDB in daily practice.
Subject(s)
Osteitis Deformans , Humans , Middle Aged , Risedronic Acid/adverse effects , Osteitis Deformans/drug therapy , Etidronic Acid/adverse effects , Japan , Diphosphonates/adverse effectsABSTRACT
BACKGROUND: Arterial calcification due to deficiency of CD73 (ACDC; OMIM 211800) is a rare genetic disease resulting in calcium deposits in arteries and small joints causing claudication, resting pain, severe joint pain, and deformities. Currently, there are no standard treatments for ACDC. Our previous work identified etidronate as a potential targeted ACDC treatment, using in vitro and in vivo disease models with patient-derived cells. In this study, we test the safety and effectiveness of etidronate in attenuating the progression of lower-extremity arterial calcification and vascular blood flow based on the computed tomography (CT) calcium score and ankle-brachial index (ABI). METHODS: Seven adult patients with a confirmed genetic diagnosis of ACDC were enrolled in an open-label, nonrandomized, single-arm pilot study for etidronate treatment. They took etidronate daily for 14 days every 3 months and were examined at the NIH Clinical Center bi-annually for 3 years. They received a baseline evaluation as well as yearly follow up after treatment. Study visits included imaging studies, exercise tolerance tests with ABIs, clinical blood and urine testing, and full dental exams. RESULTS: Etidronate treatment appeared to have slowed the progression of further vascular calcification in lower extremities as measured by CT but did not have an effect in reversing vascular and/or periarticular joint calcifications in our small ACDC cohort. CONCLUSIONS: Etidronate was found to be safe and well tolerated by our patients and, despite the small sample size, appeared to show an effect in slowing the progression of calcification in our ACDC patient cohort.(ClinicalTrials.gov Identifier NCT01585402).
Subject(s)
5'-Nucleotidase , Etidronic Acid , GPI-Linked Proteins , Vascular Calcification , Humans , Pilot Projects , Vascular Calcification/drug therapy , Vascular Calcification/diagnostic imaging , Etidronic Acid/therapeutic use , Etidronic Acid/adverse effects , Male , Female , Middle Aged , Treatment Outcome , 5'-Nucleotidase/genetics , 5'-Nucleotidase/deficiency , Time Factors , GPI-Linked Proteins/blood , Ankle Brachial Index , Adult , Bone Density Conservation Agents/therapeutic use , Bone Density Conservation Agents/adverse effects , Disease Progression , Peripheral Arterial Disease/drug therapy , Peripheral Arterial Disease/diagnosis , Peripheral Arterial Disease/physiopathology , Aged , Lower Extremity/blood supply , Computed Tomography Angiography , Genetic Predisposition to Disease , Regional Blood FlowABSTRACT
BACKGROUND: Osteoporosis is an abnormal reduction in bone mass and bone deterioration, leading to increased fracture risk. Etidronate belongs to the bisphosphonate class of drugs which act to inhibit bone resorption by interfering with the activity of osteoclasts - bone cells that break down bone tissue. This is an update of a Cochrane review first published in 2008. For clinical relevance, we investigated etidronate's effects on postmenopausal women stratified by fracture risk (low versus high). OBJECTIVES: To assess the benefits and harms of intermittent/cyclic etidronate in the primary and secondary prevention of osteoporotic fractures in postmenopausal women at lower and higher risk of fracture, respectively. SEARCH METHODS: We searched the Cochrane Central Register of Control Trials (CENTRAL), MEDLINE, Embase, two clinical trial registers, the websites of drug approval agencies, and the bibliographies of relevant systematic reviews. We identified eligible trials published between 1966 and February 2023. SELECTION CRITERIA: We included randomized controlled trials that assessed the benefits and harms of etidronate in the prevention of fractures for postmenopausal women. Women in the experimental arms must have received at least one year of etidronate, with or without other anti-osteoporotic drugs and concurrent calcium/vitamin D. Eligible comparators were placebo (i.e. no treatment; or calcium, vitamin D, or both) or another anti-osteoporotic drug. Major outcomes were clinical vertebral, non-vertebral, hip, and wrist fractures, withdrawals due to adverse events, and serious adverse events. We classified a study as secondary prevention if its population fulfilled one or more of the following hierarchical criteria: a diagnosis of osteoporosis, a history of vertebral fractures, a low bone mineral density T-score (≤ -2.5), or aged 75 years or older. If none of these criteria were met, we considered the study to be primary prevention. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. The review has three main comparisons: (1) etidronate 400 mg/day versus placebo; (2) etidronate 200 mg/day versus placebo; (3) etidronate at any dosage versus another anti-osteoporotic agent. We stratified the analyses for each comparison into primary and secondary prevention studies. For major outcomes in the placebo-controlled studies of etidronate 400 mg/day, we followed our original review by defining a greater than 15% relative change as clinically important. For all outcomes of interest, we extracted outcome measurements at the longest time point in the study. MAIN RESULTS: Thirty studies met the review's eligibility criteria. Of these, 26 studies, with a total of 2770 women, reported data that we could extract and quantitatively synthesize. There were nine primary and 17 secondary prevention studies. We had concerns about at least one risk of bias domain in each study. None of the studies described appropriate methods for allocation concealment, although 27% described adequate methods of random sequence generation. We judged that only 8% of the studies avoided performance bias, and provided adequate descriptions of appropriate blinding methods. One-quarter of studies that reported efficacy outcomes were at high risk of attrition bias, whilst 23% of studies reporting safety outcomes were at high risk in this domain. The 30 included studies compared (1) etidronate 400 mg/day to placebo (13 studies: nine primary and four secondary prevention); (2) etidronate 200 mg/day to placebo (three studies, all secondary prevention); or (3) etidronate (both dosing regimens) to another anti-osteoporotic agent (14 studies: one primary and 13 secondary prevention). We discuss only the etidronate 400 mg/day versus placebo comparison here. For primary prevention, we collected moderate- to very low-certainty evidence from nine studies (one to four years in length) including 740 postmenopausal women at lower risk of fractures. Compared to placebo, etidronate 400 mg/day probably results in little to no difference in non-vertebral fractures (risk ratio (RR) 0.56, 95% confidence interval (CI) 0.20 to 1.61); absolute risk reduction (ARR) 4.8% fewer, 95% CI 8.9% fewer to 6.1% more) and serious adverse events (RR 0.90, 95% CI 0.52 to 1.54; ARR 1.1% fewer, 95% CI 4.9% fewer to 5.3% more), based on moderate-certainty evidence. Etidronate 400 mg/day may result in little to no difference in clinical vertebral fractures (RR 3.03, 95% CI 0.32 to 28.44; ARR 0.02% more, 95% CI 0% fewer to 0% more) and withdrawals due to adverse events (RR 1.41, 95% CI 0.81 to 2.47; ARR 2.3% more, 95% CI 1.1% fewer to 8.4% more), based on low-certainty evidence. We do not know the effect of etidronate on hip fractures because the evidence is very uncertain (RR not estimable based on very low-certainty evidence). Wrist fractures were not reported in the included studies. For secondary prevention, four studies (two to four years in length) including 667 postmenopausal women at higher risk of fractures provided the evidence. Compared to placebo, etidronate 400 mg/day may make little or no difference to non-vertebral fractures (RR 1.07, 95% CI 0.72 to 1.58; ARR 0.9% more, 95% CI 3.8% fewer to 8.1% more), based on low-certainty evidence. The evidence is very uncertain about etidronate's effects on hip fractures (RR 0.93, 95% CI 0.17 to 5.19; ARR 0.0% fewer, 95% CI 1.2% fewer to 6.3% more), wrist fractures (RR 0.90, 95% CI 0.13 to 6.04; ARR 0.0% fewer, 95% CI 2.5% fewer to 15.9% more), withdrawals due to adverse events (RR 1.09, 95% CI 0.54 to 2.18; ARR 0.4% more, 95% CI 1.9% fewer to 4.9% more), and serious adverse events (RR not estimable), compared to placebo. Clinical vertebral fractures were not reported in the included studies. AUTHORS' CONCLUSIONS: This update echoes the key findings of our previous review that etidronate probably makes or may make little to no difference to vertebral and non-vertebral fractures for both primary and secondary prevention.
Subject(s)
Hip Fractures , Osteoporosis , Osteoporotic Fractures , Spinal Fractures , Wrist Fractures , Wrist Injuries , Humans , Female , Osteoporotic Fractures/prevention & control , Osteoporotic Fractures/chemically induced , Osteoporotic Fractures/drug therapy , Etidronic Acid/therapeutic use , Secondary Prevention , Calcium , Postmenopause , Osteoporosis/drug therapy , Spinal Fractures/prevention & control , Vitamin D , Wrist Injuries/chemically induced , Wrist Injuries/drug therapyABSTRACT
BACKGROUND: Growth factors embedded in the extracellular matrix of the dentin play an important role in the migration, proliferation, and differentiation of dental pulp stem cells in regenerative endodontics. In regenerative endodontic treatments, the type of irrigation solution used is crucial for the release of growth factors (GFs) from the dentin matrix. This study evaluated the effectiveness of different irrigant activation techniques (IAT) using two different chelating agents, 17% ethylenediaminetetraacetic acid (EDTA) and 9% etidronic acid (HEDP), in terms of their GF release. METHODS: Seventy-two mandibular premolar teeth were prepared to simulate an open apex. The root fragments were irrigated with 20 ml of 1.5% sodium hypochlorite and 20 ml of saline solution. Eight root fragments were randomly separated for the control group, and the remaining 64 fragments were randomly separated into eight groups based on two different chelating agents (17% EDTA and 9% HEDP) and four different IAT ((conventional needle irrigation (CNI), passive ultrasonic irrigation (PUI), sonic activation with EDDY, and XP-endo Finisher (XPF)). TGF-ß1, VEGF-A, BMP-7 and IGF-1 release levels were determined using an ELISA, and statistical analysis was performed using the Kolmogorov-Smirnov test, ANOVA, and the Tukey test (p < .05). RESULTS: Compared to the control group, the experimental groups showed significantly higher GF release when using EDTA or HEDP. Among the activation groups, the EDDY group triggered the highest GF release, and the CNI group triggered the lowest. CONCLUSIONS: IAT with EDTA and HEDP can increase GF release, with EDDY being the most effective IAT method. Using chelating agents with IAT may be beneficial in regenerative endodontic treatments.
Subject(s)
Chelating Agents , Dentin , Edetic Acid , Etidronic Acid , Root Canal Irrigants , Humans , Root Canal Irrigants/pharmacology , Dentin/drug effects , Etidronic Acid/pharmacology , Chelating Agents/pharmacology , In Vitro Techniques , Intercellular Signaling Peptides and Proteins , Regenerative Endodontics/methods , Bicuspid , Root Canal Preparation/methodsABSTRACT
The prevalence of plant diseases caused by pathogens such as Xanthomonas campestris pv campestris (Xcc) poses a significant challenge to sustainable agriculture, necessitating the development of effective and eco-friendly disinfection methods. In this study, we investigated the efficacy of electrohydraulic discharge plasma (EHDP) as a promising alternative for disinfection against Xcc, a pathogen responsible for black rot in cruciferous vegetables. Unlike conventional gas-phase plasma, EHDP introduces two pivotal components: gas-liquid interface plasma (GLIP) and its consequential byproduct, plasma-activated water (PAW). While GLIP enables dual-phase production of reactive oxygen and nitrogen species (RONS), PAW is a reservoir of liquid-phase long-lived RONS, thereby enhancing its bactericidal efficacy. In our evaluations, we tested EHDP-induced GLIP and EHDP-induced PAW against Xcc cells in both in vitro (Xcc suspension) and in vivo (Xcc-inoculated cabbage seeds) settings, achieving noteworthy results. Within 15 min, these methods eliminated â¼98% of the Xcc cells in suspension. For in vivo assessments, nontreated seeds exhibited an infection rate of 98%. In contrast, both EHDP treatments showed a significant reduction, with â¼60% fewer seeds infected while maintaining â¼90% germination rate. In addition, the liquid-phase RONS in EHDP-PAW may enhance seed vigor with a faster germination rate within the initial 5 days. Remarkably, around 90% of EHDP-PAW-treated seeds yielded healthy seedlings, indicating dual benefits in bacterial suppression and seed growth stimulation. In contrast, the percentage of healthy seedlings from nontreated, Xcc-inoculated seeds was approximately 70%. Our research demonstrates the feasibility of using eco-friendly EHDP in the seed disinfection process.
Subject(s)
Body Fluids , Xanthomonas campestris , Disinfection/methods , Etidronic Acid , Seeds/microbiology , GasesABSTRACT
BACKGROUND: Fahr's disease and syndrome are rare disorders leading to calcification of the small arteries in the basal ganglia of the brain, resulting in a wide range of symptoms comprising cognitive decline, movement disorders and neuropsychiatric symptoms. No disease-modifying therapies are available. Studies have shown the potential of treatment of ectopic vascular calcifications with bisphosphonates. This paper describes the rationale and design of the CALCIFADE trial which evaluates the effects of etidronate in patients with Fahr's disease or syndrome. METHODS: The CALCIFADE trial is a randomised, placebo-controlled, double-blind trial which evaluates the effects of etidronate 20 mg/kg during 12 months follow-up in patients aged ≥ 18 years with Fahr's disease or syndrome. Etidronate and placebo will be administered in capsules daily for two weeks on followed by ten weeks off. The study will be conducted at the outpatient clinic of the University Medical Center Utrecht, the Netherlands. The primary endpoint is the change in cognitive functioning after 12 months of treatment. Secondary endpoints are the change in mobility, neuropsychiatric symptoms, volume of brain calcifications, dependence in activities of daily living, and quality of life. RESULTS: Patient recruitment started in April 2023. Results are expected in 2026 and will be disseminated through peer-reviewed journals as well as presentations at national and international conferences. CONCLUSIONS: Fahr's disease and syndrome are slowly progressive disorders with a negative impact on a variety of health outcomes. Etidronate might be a new promising treatment for patients with Fahr's disease or syndrome. TRIAL REGISTRATION: ClinicalTrials.gov, NCT05662111. Registered 22 December 2022, https://clinicaltrials.gov/ct2/show/NCT01585402 .
Subject(s)
Basal Ganglia Diseases , Calcinosis , Etidronic Acid , Neurodegenerative Diseases , Humans , Etidronic Acid/therapeutic use , Activities of Daily Living , Quality of Life , Basal Ganglia Diseases/complications , Basal Ganglia Diseases/diagnosis , Basal Ganglia Diseases/psychology , BrainABSTRACT
Phosphonates have received a widespread attention in wastewater treatment due to their potential threat to the water environment. Advanced oxidation processes (AOPs) are feasible methods to degrade phosphonates, and most of the coexisting substances in water show a negative factor during their oxidation. However, the effect of bromide (Br-) on the degradation of phosphonates in peroxymonosulfate (PMS) activation is still unclear. Herein, using 1-hydroxyethane 1,1-diphosphonic acid (HEDP) as a target phosphonate, Br- could remarkably enhance the degradation of HEDP in PMS activation compared to the PMS alone. Under the condition of pH = 7.0, the optimal degradation efficiency of HEDP is 84.8% in the PMS/Br- process after 30-min reaction, whereas no significant oxidation is obtained in the PMS/I- and PMS/Cl- processes. Multiple experiments (i.e., electron paramagnetic resonance (EPR), radical quenching experiments and chemical probs) confirm that free bromine, SO4â¢- and HO⢠paly a minor role in HEDP removal, and bromine radical species make a dominant responsible for HEDP oxidation. Additionally, NO3-, SO42-, Cl-, and HCO3- have a little effect on the degradation of HEDP, but the HEDP removal is greatly inhibited in the presence of humic acid (HA). However, the degradation efficiency of HEDP using PMS/Br- process in river and sewage is a much higher than UV/persulfate (PDS) and UV/H2O2 processes. This study provides a new sight into the effect of Br- on the degradation phosphonates in PMS activation process.
Subject(s)
Organophosphonates , Water Pollutants, Chemical , Hydrogen Peroxide/chemistry , Bromides , Bromine , Etidronic Acid , Water Pollutants, Chemical/analysis , Peroxides/chemistry , Oxidation-Reduction , WaterABSTRACT
This study aimed to evaluate the dislodgement resistance and structural changes of different mineral trioxide aggregate cements (MTA) like Pro-Root MTA, Ortho MTA, and Retro MTA after exposure to sodium hypochlorite (NaOCl), NaOCl-Ethylenediaminetetraacetic acid (EDTA), 1-hydroxyethylidene-1, 1-bisphosphonate (Dual Rinse HEDP), and NaOCl-Maleic acid (MA). The root canal spaces of 150 dentine slices were obturated using tricalcium silicate cements and divided into 3 groups (n = 50): Group1: ProRoot MTA, Group2: Retro MTA, and Group3: Ortho MTA. The samples in each group were further subdivided into four experimental (n = 10) and one control groups (n = 10): 2.5% NaOCl-17% EDTA, Dual Rinse HEDP, 2.5% NaOCl-7% Maleic acid, 2.5% NaOCl, distilled water (control). The dislodgement resistance and structural changes of cements were measured. Use of DR HEDP resulted in higher dislodgement resistance compared to17% EDTA and 7% MA in the samples obturated with Ortho MTA and Pro-Root MTA (p<0.001). In Retro MTA group, samples treated with DR HEDP and 17% EDTA had higher dislodgment resistance compared to 7% MA (p<0.001). On microstructural and elemental analysis of all the three MTA cements, samples treated with 17% EDTA and 7% MA were more amorphous and granular when compared to DR HEDP, which was pettle shaped. Calcium level was decreased more in samples treated with 17% EDTA and 7% MA when compared to DR HEDP.
Subject(s)
Chelating Agents , Etidronic Acid , Maleates , Chelating Agents/pharmacology , Edetic Acid/pharmacology , Calcium Compounds/pharmacology , Calcium Compounds/chemistry , Silicates/pharmacology , Silicates/chemistry , Drug Combinations , Oxides/pharmacology , Oxides/chemistryABSTRACT
OBJECTIVES: To evaluate the mechanical properties of root canal dentin treated with sodium hypochlorite (NaOCl) in combination with hydroxyethylidene diphosphonic acid (HEDP) or ethylenediaminetetraacetic acid (EDTA). METHODS: For testing fracture resistance, 45 single-rooted teeth were instrumented and irrigated with NaOCl/HEDP, NaOCl/EDTA, or distilled water. Fifteen untreated teeth served as control. After obturation, specimens from the experimental groups were thermocycled, dynamically-loaded, and then statically-loaded in a universal testing machine until failure. For flexural strength analysis, 15 teeth were instrumented and irrigated with NaOCl/HEDP or NaOCl/EDTA. Root segments were sectioned into dentin bars and tested for flexural strength using a universal testing machine. For microhardness evaluation, 20 teeth were instrumented and irrigated with NaOCl/HEDP or NaOCl/EDTA. Dentin disks from the coronal-third of each root segment were prepared, one before and one after irrigation, for microhardness testing with a Knoop hardness tester. RESULTS: The highest fracture resistance was recorded in the untreated group, and the lowest in the EDTA group. Although the HEDP group had higher fracture resistance than the EDTA group, the distilled water group demonstrated even greater fracture resistance than the HEDP group. Specimens treated with HEDP had significantly higher flexural strength and microhardness values when compared with those treated with EDTA. CONCLUSION: The fracture resistance, flexural strength, and microhardness of root canal dentin were higher when root canals were irrigated with NaOCl/HEDP, when compared with NaOCl/EDTA. CLINICAL SIGNIFICANCE: Irrigating root canals with NaOCl combined with HEDP significantly improves the mechanical integrity of root canal dentin compared to the use of NaOCl with EDTA.
Subject(s)
Chelating Agents , Dentin , Edetic Acid , Hardness , Materials Testing , Root Canal Irrigants , Sodium Hypochlorite , Dentin/drug effects , Sodium Hypochlorite/pharmacology , Humans , Edetic Acid/pharmacology , Root Canal Irrigants/pharmacology , Chelating Agents/pharmacology , Stress, Mechanical , Etidronic Acid/pharmacology , Dental Pulp Cavity/drug effects , Flexural Strength , Dental Stress Analysis , Root Canal Preparation/methods , Tooth Fractures/prevention & control , Tooth Root/drug effects , Pliability , Temperature , Root Canal Obturation/methodsSubject(s)
Bone Density Conservation Agents , Bone Density , Etidronic Acid , Aged , Female , Humans , Middle Aged , Bone Density/drug effects , Bone Density Conservation Agents/therapeutic use , Drug Therapy, Combination , Estrogens/administration & dosage , Etidronic Acid/therapeutic use , Lumbar Vertebrae , Osteoporosis, Postmenopausal/drug therapyABSTRACT
ABSTRACT Objective To evaluate and compare the effect of 17% Ethylenediaminetetraacetic Acid (EDTA), 9% Etidronic acid (HEDP), and 7% Maleic acid (MA) on the push-out bond strength of NeoMTA Plus sealer to the coronal, middle, and apical thirds of root canal dentin. Material and Methods Forty single-rooted human maxillary central incisors were selected and decoronated to 12 mm long root fragments. Working length was established and root canals were then enlarged up to rotary Protaper F3. After each instrumentation, the root canal was irrigated with 2.5% NaOCl. For the final irrigation regimen, the specimens were divided into 4 groups (n=10) and treated with EDTA, HEDP, MA or Saline. Root canals were coated with NeoMTA Plus sealer, and obturation was done with single cone obturation technique. Subsequently, three horizontal sections were taken from the coronal, middle and apical thirds of each specimen, and POBS was measured using a universal testing machine. The type of bond failures was assessed under a stereomicroscope. Statistical analysis was done with One-way ANOVA with Tukey's Post hoc analysis. Results MA and EDTA showed the highest POBS. There was no significant difference in bond strength between MA and EDTA (p>0.05). HEDP and Saline showed lower POBS. Among all the four groups, the coronal third showed the highest values, followed by middle and apical thirds. Conclusion The type of chelating agent used during the root canal treatment significantly affects the bond strength of NeoMTA Plus to the root canal dentin.
Subject(s)
Humans , Root Canal Filling Materials , Tensile Strength , Chelating Agents/chemistry , Dental Cements , Endodontics , Analysis of Variance , Edetic Acid , Etidronic Acid , Dental Materials/chemistry , Incisor , India , Maleic HydrazideABSTRACT
Determinar la actividad antimicrobiana de la pasta en gel de dientes contra dos microorganismos: mutans Streptococccus y Actinobacillus actinomycetemcomitans...
Subject(s)
Humans , Etidronic Acid/therapeutic use , Aggregatibacter actinomycetemcomitans , Anti-Bacterial Agents/therapeutic use , Gels , Toothpastes/therapeutic use , Streptococcus mutans , Bacterial Adhesion , Culture Media , Drug Compounding/trends , Diphosphonates/therapeutic use , Colony Count, Microbial/methodsABSTRACT
Avaliar, por microscopia eletrônica de varredura (MEV), o efeito do uso individual e combinado do etidronato 18% (HEBP) na remoção da smear layer do canal radicular. Métodos: Trinta dentes humanos unirradiculares foram utilizados. As raízes foram preparadas com instrumentos rotatórios do Sistema ProTaper Universal e divididas aleatoriamente em três grupos, de acordo com o protocolo de irrigação empregado: G1 = hipoclorito de sódio 2,5% (NaOCl) e ácido etilenodiaminotetracético 17% (EDTA); G2 = NaOCl 2,5% e HEBP 18%; e G3 = NaOCl 2,5% + HEBP 18%, misturados em partes iguais. As raízes foram seccionadas longitudinalmente e metalizadas, para análise em MEV. As fotomicrografias obtidas dos terços cervical, médio e apical foram avaliadas por três examinadores calibrados, que atribuíram escores de 1 a 5 às imagens. Os grupos experimentais foram comparados usando o teste de Kruskal-Wallis e o teste de Student-New- man-Keuls. Os terços radiculares foram comparados pelo teste de Friedman. O nível de significância foi estabelecido em 5%. Resultados: A capacidade de remoção da smear layer com NaOCl 2,5% e 18% HEBP (G2) foi semelhante à obtida com NaOCl 2,5% e EDTA 17% (G1) no terço médio e cervical da raiz; o nível de limpeza do terço apical foi semelhante, independentemente do protocolo de irrigação utilizado. Conclusão: HEBP é uma solução promissora para uso em tratamentos endodônticos (AU).
Introduction: We evaluated the effect of individual and combined use of 18% etidronate (HEBP) in root canal smear layer removal using scanning electron microscopy (SEM). Methods: Thirty human single-rooted teeth were used. The roots were prepared with ProTaper Universal System rotary files and randomly divided into three groups according to the irrigation protocol used. G1: 2.5% sodium hypochlorite (NaOCl) and 17% ethylenediaminetetraacetic acid (EDTA); G2: 2.5% NaOCl and 18% HEBP; and G3: 2.5% NaOCl + HEBP 18%, mixed in equal parts. The roots were sectioned longitudinally and metallized for SEM analysis. The photomicrographs obtained from the cervical, middle, and apical thirds were evaluated by three calibrated examiners, who assigned scores from 1 to 5 to the images. The experimental groups were compared using the Kruskal-Wallis test and the Student-Newman-Keuls test. Root thirds were compared by the Friedman test. The level of significance was set at 5%. Results: The capacity for removal of the smear layer by 2.5% NaOCl and 18% HEBP (G2) was similar to that achieved with 2.5% NaOCl and 17% EDTA (G1) in the cervical and middle thirds of the root; the cleansing level of the apical third was similar, regardless of the irrigation protocol used. Conclusion: HEBP is a promising solution for use in endodontic treatments (AU).
Subject(s)
Humans , Microscopy, Electron, Scanning , Etidronic Acid , Lifting , Dental Pulp Cavity , Solutions , Efficacy , Dissolution , Organic MatterABSTRACT
The purpose of this in vitro study was to evaluate the effect of various chelating solutions on the radicular push-out bond strength of calcium silicate-based and resin-based root canal sealers. Root canals of freshly-extracted single-rooted teeth (n = 80) were instrumented by using rotary instruments. The specimens were randomly divided into 4 groups according to the chelating solutions being tested: (1) 17% ethylenediaminetetraacetic acid (EDTA); (2) 9% etidronic acid; (3) 1% peracetic acid (PAA); and (4) distilled water (control). In each group, the roots were further assigned into 2 subgroups according to the sealer used: (1) an epoxy resin-based sealer (AH Plus) and (2) a calcium silicate-based sealer (iRoot SP). Four 1 mm-thick sections were obtained from the coronal aspect of each root (n = 40 slices/group). Push-out bond strength test was performed at a crosshead speed of 1 mm/min., and the bond strength data were analyzed statistically with two-way analysis of variance (ANOVA) with Bonferroni’s post hoc test (p < 0.05). Failure modes were assessed quantitatively under a stereomicroscope. Irrespective of the irrigation regimens, iRoot SP exhibited significantly higher push-out bond strength values than AH Plus (p < 0.05). For both the sealers, the use of chelating solutions increased the bond strength, but to levels that were not significantly greater than their respective controls (p > 0.05). iRoot SP showed higher resistance to dislocation than AH Plus. Final irrigation with 17% EDTA, 9% Etidronic acid, and 1% PAA did not improve the bond strength of AH Plus and iRoot SP to radicular dentin.
Subject(s)
Humans , Chelating Agents/chemistry , Dental Bonding/methods , Dental Pulp Cavity/drug effects , Dentin/drug effects , Root Canal Filling Materials/chemistry , Root Canal Irrigants/chemistry , Analysis of Variance , Dental Restoration Failure , Edetic Acid/chemistry , Etidronic Acid/chemistry , Materials Testing , Peracetic Acid/chemistry , Random Allocation , Reproducibility of Results , Surface Properties/drug effects , Time FactorsABSTRACT
O objetivo do trabalho foi investigar o efeito de diferentes soluções químicas auxiliares, em concentrações subcitotóxicas, na expressão de citocinas pró e anti-inflamatórias, quando em contato com células da linhagem de linfoma humano, diferenciadas em macrófagos, human macrophage-like (U937), através da adição de 125ng/mL de PMA. As concentrações, citotóxica e subcitotóxica, de cada solução, foram determinadas de acordo com padrão ISO, utilizando-se fibroblastos de camundongos (L929). As células L929 foram cultivadas em meio MEM completo e mantidas em placas de 96 poços. As células foram então colocadas em contato com as diluições das soluções químicas auxiliares (a partir das concentrações recomendadas para uso, NaOCL 5,25%; CHX 2%; Quitosana 0,2%; HEBP 18%; GSE de Vitis vinífera, 6,5%), por 24 horas a 37ºC em estufa de CO2. Em seguida, o meio de cultivo contendo 1mg/mL de MTT foi adicionado aos poços em triplicata, para avaliação da viabilidade celular e determinação das concentrações citotóxicas (30% de morte das células L929) e subcitotóxicas (15% de morte) por regressão linear por meio do programa GraphPad Prism versão 6.0. As concentrações subcitotóxicas foram colocadas em contato com as células human macrophage-like (U937) por 60 min. Os sobrenadantes da pré-incubação (controles sem substâncias químicas auxiliares), e incubação com as soluções químicas auxiliares em meio DMEM completo foram congelados em freezer ultrafrio ( 80ºC) e avaliados para as concentrações de dezessete citocinas através do kit Bio-Plex Pro Human Th17 Cytokine Panel® pelo método Luminex®. Foi possível obter valores de expressão de 7 citocinas pró-inflamatórias: IL-1ß, TNFα, IL-6, IL-17A, IL-17F, IL-22 e IL-23. As substâncias com maior atividade citotóxica (padrão ISO para morte celular) foram em ordem de grandeza, a quitosana, a CHX, o NaOCl, o HEBP e o GSE de Vitis vinifera. As concentrações subcitotóxicas das soluções químicas auxiliares, CHX e NaOCl, induziram ao aumento da maioria das citocinas pró-inflamatórias, exceto para a IL-6. Quanto a IL-1ß, a quitosana e a CHX, estas foram as que mais induziram a expressão pelas células U937 (P<0,05),enquanto o NaOCl induziu maior expressão de TNFα (P>0,05). Dentre as citocinas relacionadas ao fenótipo Th17, a CHX foi a que mais induziu a expressão de IL-17A (P<0,05), IL-17F e IL-23, seguido do NaOCl(P<0,05). O NaOCl induziu maior expressão de IL22 seguido da CHX (p<0,05). Quanto a IL-6, todas as substâncias modularam a sua expressão pelas células U937(p>0.05). O HEBP atuou como um excelente modulador da expressão de citocinas pró-inflamatórias, induzindo a redução da expressão de todas as citocinas testadas (P<0,05). O GSE de Vitis vinifera, apesar de ser o menos citotóxico não apresentou diferença estatística para o controle em nenhuma das situações avaliadas, exceto para a redução da IL-6 (assim como o HEBP e a quitosana) (p<0,05). A quitosana comportou-se de forma similar ao GSE de Vitis vinífera (p>0,05) exceto para a IL-1ß. Conforme observado, as substâncias químicas auxiliares são capazes de induzir a expressão de citocinas pró-inflamatórias diversas. O HEBP foi o agente químico que melhor modulou a expressão de citocinas pró-inflamatórias.
The aim of this investigation was to analyze the effect of different chemical endodontic solutions, in subcytotoxic concentrations, on the expression of pro and anti-inflammatory cytokines when in contact with human lymphoma lineage differentiated into human macrophages, human macrophage-like (U937), by the addition of 125ng/ml PMA. The cytotoxic and subcytotoxic concentrations of each solution were determined according to ISO standard using mouse fibroblasts (L929). L929 cells were cultured in complete MEM medium and maintained in 96-well plates. Dilutions of the auxiliary chemical solutions, from the recommended concentrations for use: NaOCL 5,25%; CHX 2%; Chitosan 0.2%; Etidronic acid 18% and Grape seed extract, Vitis vinifera, 6.5%, were carried out in complete MEM medium, and placed in contact with the cells for 24 hours at 37ºC in CO2 cell incubator, in triplicate. Thereafter, the culture medium containing 1 mg/mL MTT was added to the wells. Cytotoxic concentrations (30% death of L929 cells) and subcytotoxic (15% death) were determined by linear regression using GraphPad Prism version 6.0. Subcytotoxic concentrations were obtained in complete DMEM medium and maintained in contact for 60 min. with U937 cells. Controls without chemical substances were also performed. Supernatants from the pre-incubation, incubation with the chemical solutions and complete DMEM were removed, frozen in ultra-cold freezer (-80ºC) and evaluated for the concentrations of 17 cytokines through the Bio-Plex Pro Human Th17 Cytokine Panel® kit by Luminex®. The substances with higher cytotoxic activity were in order of magnitude: chitosan, CHX, NaOCl, etidronic acid and Vitis vinifera extract. The values of 7 pro-inflammatory cytokines: IL-1ß, TNFα, IL-6, IL-17A, IL-17F, IL-22 and IL-23 were obtained. Subcytotoxic concentrations of the irrigant agents (chlorhexidine and NaOCl) generally induced the increase of most pro-inflammatory cytokines, except for IL-6. Chitosan and CHX were the agents that most induced the expression of IL-1ß by U937 cells, whereas NaOCl induced higher TNFα expression (P> 0,05). Among the cytokines related to the Th17 phenotype, CHX was the agent that induced the highest expression of IL-17A (P <0,05), IL-17F and IL-23, followed by NaOCl (P<0,05). NaOCl induced the highest expression of IL22 followed by CHX. All of the substances modulated the expression of IL-6 by U937 cells (P >0,05). HEBP was an excellent modulator of the expression of pro-inflammatory cytokines, inducing the reduction of the expression of all cytokines tested. Vitis vinifera extract, despite being the least cytotoxic agent, did not present statistical differences compared to the control for any of the evaluated cytokines, except for the reduction of IL-6 (as well as etidronic acid and chitosan) (P<0,05). Chitosan, except for IL-1 ß, was very similar to the Vitis vinifera (P>0,05) extract. As observed, the auxiliary substances (especially the irrigants) are capable of inducing the expression of various pro-inflammatory cytokines. Etidronic acid was the chemical that modulated the expression of pro-inflammatory cytokines.
Subject(s)
Humans , Root Canal Irrigants/pharmacology , Cytokines , U937 Cells , Sodium Hypochlorite , In Vitro Techniques , Chlorhexidine , Etidronic Acid , Chitosan , Grape Seed ExtractABSTRACT
An increase in dentin roughness, associated with surface composition, contributes to bacterial adherence in recontaminations. Surface roughness is also important for micromechanical interlocking of dental materials to dentin, and understanding the characteristics of the surface is essential to obtain the adhesion of root canal sealers that have different physico-chemical characteristics. OBJECTIVES: To evaluate the effects of sodium hypochlorite (NaOCl), ethylenediaminetetraacetic (EDTA), etidronic (HEBP), and citric acid (CA) associated with different irrigation regimens on root dentin roughness. MATERIAL AND METHODS: Forty-five root halves of anterior teeth were used. The root parts were sectioned in thirds, embedded in acrylic resin and polished to a standard surface roughness. Initially, the samples of each third were randomly assigned into 3 groups and treated as follows: G1 - saline solution (control); G2 - 5% NaOCl+18% HEBP mixed in equal parts; and G3 - 2.5% NaOCl. After initial measuments, the G3 samples were distributed into subgroups G4, G5 and G6, which were subjected to 17% EDTA, 10% CA and 9% HEBP, respectively. Following the new measuments, these groups received a final flush with 2.5% NaOCl, producing G7, G8 and G9. The dentin surface roughness (Ra) was determined before and after treatments using a profilometer. The Wilcoxon test (α<0.05) was used to compare the values before and after treatments, and the Friedman test (α<0.05) to detect any differences among root thirds. RESULTS: (i) NaOCl did not affect the surface roughness; (ii) there was a significant increase in roughness after the use of chelating agents (P<0.01); and (iii) only the G3 group showed a difference in surface roughness between apical third and other thirds of the teeth (P<0.0043). CONCLUSION: Only the irrigation regimens that used chelating agents altered the roughness of root dentin. .
Subject(s)
Humans , Dentin/drug effects , Etidronic Acid/pharmacology , Root Canal Irrigants/pharmacology , Root Canal Preparation/methods , Tooth Root/drug effects , Chelating Agents/pharmacology , Citric Acid/pharmacology , Disinfectants/pharmacology , Edetic Acid/pharmacology , Reference Values , Reproducibility of Results , Sodium Hypochlorite/pharmacology , Statistics, Nonparametric , Surface Properties/drug effects , Time FactorsABSTRACT
Besides of the desired effects, the chemical solutions used to assist the endodontic instruments in the cleanliness and disinfection of the root canal system can also cause changes in the physicochemical properties of dentin, and consequently affect the adhesion of endodontic sealers and microorganisms to the root canal walls. However, the effects of new irrigators and irrigation protocols remain unknown. The objectives of this thesis were to verify the alterations in the properties of some irrigants when used combined in mixtures, to define the time necessary for the smear layer removal by a new irrigant, to determine the organic matter dissolution capacity and the effects in the physicochemical properties of dentin of some irrigation solutions and protocols, and to evaluate the adhesion of microorganisms and AH Plus sealer to dentin after its submission to different irrigation sequences. In all experiments with dentin, the samples used were obtained from bovine teeth. In the analysis performed in this thesis, the following solutions were tested isolated and combined in different irrigation protocols: saline solution (control), sodium hypochlorite (NaOCl), trisodium (EDTAHNa3), alkaline ethylenediaminetetraacetic acid tetrasodium (EDTANa4), chlorhexidine (CHX), peracetic acid (PAA), and etidronic acid (HEDP). The EDTAHNa3 and EDTANa4 were tested in relation to their effects on the free chlorine content of NaOCl. The solutions were mixed in a 1:1 ratio and the iodometric titration of the mixtures performed in different time intervals. The time necessary for smear layer removal from dentin samples by solutions of EDTAHNa3 and different concentrations of EDTANa4 isolated and mixed with NaOCl was determined with the aid of the scanning electron microscope (SEM). The capacity of NaOCl to dissolve organic matter was determined by weighting fragments of bovine muscle before and after immersion in solutions of 1%, 2.5%, and 5% of NaOCl in different periods of time. Also, the effects of EDTAHNa3, EDTANa4 and HEDP on the organic matter dissolution by NaOCl were evaluated. The alterations produced by all solutions isolated and some irrigation protocols in the organic and inorganic components of the dentin surface were analysed by the attenuated total reflectance of Fourier transform infrared spectroscopy (ATR-FTIR) technique. Absorbance spectra were collected from the dentin surface before and after immersion of samples in the irrigants and the ratios of the amide III/phosphate and carbonate/phosphate bands were calculated. To quantify the adhesion of CHX to mineralized dentin and to dentin demineralized by different irrigation protocols, the areas of the band associated with CHX with the peak in 1492 cm−1 were determined in spectra obtained by ATR-FTIR. The effects of different irrigation protocols in the roughness and wettability of dentin surface were measured with a benchtop roughness tester and the sessile drop technique, respectively. For the assays of microorganisms' adhesion, samples were prepared and treated the same way and with the same irrigation protocols used in the roughness and wettability tests. Following, Candida albicans and Enterococcus faecalis were maintained in contact with the dentin for 2 hours and the samples were analyzed on the confocal laser scanning microscope (CLSM). Tests of push-out were performed to determine the impact of different irrigation protocols on the dentin bonding strength of AH Plus sealer over time. Canals of bovine incisors teeth were instrumented, irrigated and following obturated using only the sealer AH Plus. Half of the samples were submitted to pushout assessment 7 days after the obturation and the other half 20 months later. The results of the experiments showed that the EDTAHNa3 caused an almost complete and immediate loss of free available chlorine from NaOCl, whilst EDTANa4 promoted a slow and concentration-dependent decline. The smear layer was removed only by decalcifying solutions and in about 1 min by the 17% EDTAHNa3 and 5 min by the EDTANa4, both isolated or mixed with NaOCl. The increase in NaOCl concentration and contact time with the samples intensified the dissolution of organic matter. The mixtures of NaOCl with EDTANa4 and HEDP were able to dissolve the fragments of bovine muscle over-time, however, the EDTAHNa3 strongly affected the NaOCl dissolution capacity when they were mixed. The results of ATR-FTIR experiments showed that the increase in the NaOCl concentration intensified the deproteination of the dentin collagen with a reduction in the amide III/phosphate ratio. For the same decalcifying agent, the higher the concentration and immersion time the greater the removal of phosphate, exposure of the collagen matrix and consequently the increases in amide III/phosphate ratio. The PAA caused greater increases in amide III/phosphate ratio, followed by EDTAHNa3, EDTANa4 and HEDP and this order was maintained in the protocols in which NaOCl was used before the decalcifying agents. NaOCl required approximately 0.5 min to deproteinate the collagen matrix exposed after phosphate removal by EDTAHNa3 and PAA. The carbonate/phosphate ratio decreased after 30 s of samples immersion in solutions of NaOCl at 1%, 2.5% and 5% with no more alterations over time. The carbonate of the dentine was removed faster than phosphate by all decalcifying agents employed alone and in the irrigation protocols in which the use of the NaOCl was followed by the use of the EDTAHNa3, PAA and HEDP. For irrigation protocols that associate NaOCl with chelating solutions, the last irrigant used defined the final dentine amide III/phosphate and carbonate/phosphate ratios. For the ATR-FTIR analysis of CHX adhesion, the results showed that the adsorption of this irrigant to the dentin was potentiated when chelating agents were used prior to the CHX. In relation to the experiments of surface roughness, the saline solution, NaOCl, HEDP and CHX did not alter the roughness of the dentin, but EDTAHNa3 and PAA increased it. The wettability of the surface increased after the use of all irrigants, being the HEDP to cause the greater increases. In the assays of microorganisms' adhesion, the smear layer and collagen exposed by the chelating agents favored the adhesion of E. faecalis. The C. albicans adhesion was major in surfaces with smear layer and more mineral. The use of CHX as the final irrigant reduced the adhesion of both microorganisms. The wettability did not influence the microorganisms' adhesion, while increases in roughness seems to potentiate the adherence of E. faecalis. The experiments of bond strength of AH Plus to the dentin showed that the irrigation with NaOCl and mixture of NaOCl + EDTANa4 produced the lowest push-out bond strength values in 7 days compared to NaOCl + EDTAHNa3, NaOCl + EDTAHNa3 + NaOCl, NaOCl + EDTAHNa3 + CHX and the mixture of NaOCl + HEDP. After 20 months the lowest values were obtained in the groups irrigated with NaOCl and NaOCl + EDTAHNa3. The groups of NaOCl + EDTAHNa3 + NaOCl, mixture NaOCl + HEDP, and mixture NaOCl + EDTANa4 presented values of push-out bond strength in 20 months similar to the values in 7 days. It was possible to conclude that the irrigation solutions tested in this study have different effects in the organic and inorganic matter and some of them can affect the action of each other when mixed. Independent of being used isolated or combined in irrigation protocols, these irrigants cause modifications in the dentin physicochemical properties that influence the adhesion of AH Plus sealer in short and long term and the microorganisms' adherence to the surface in cases of recontaminations.(AU)
Além dos efeitos desejados, as soluções químicas utilizadas para auxiliar os instrumentos endodônticos na limpeza e desinfecção do sistema radiculares podem causar alterações nas propriedades físico-químicas da dentina e consequentemente afetar a adesão de cimentos endodônticos e microrganismos às paredes do canal radicular. Contudo, os efeitos de novos irrigantes e protocolos de irrigação ainda são desconhecidos. Os objetivos desta tese foram verificar as alterações nas propriedades de alguns irrigantes quando utilizados combinados em misturas, definir o tempo necessário para a remoção da camada de smear layer por um novo irrigante, determinar a capacidade de dissolução de matéria orgânica e os efeitos de algumas soluções e protocolos de irrigação nas propriedades físico-químicas de dentina e avaliar a adesão de microrganismos e cimento AH Plus à dentina após a submissão desta a diferentes sequências de irrigação. Em todos os experimentos com dentina as amostras utilizadas foram obtidas a partir de dentes bovinos. Nas análise realizadas nesta tese as seguintes soluções foram testadas isoladas e combinadas em diferentes protocolos de irrigação: solução salina (controle), hipoclorito de sódio (NaOCl), ácido etilenodiaminotetraacético trisódico (EDTAHNa3), ácido etilenodiaminotetracético tetrassódico alcalino (EDTANa4), clorexidina (CHX), ácido peracético (PAA) e ácido etidrônico (HEDP). O EDTAHNa3 e o EDTANa4 foram testados em relação aos seus efeitos sobre o teor de cloro livre do NaOCl. As soluções foram misturadas em uma proporção de 1:1 e a titulação iodométrica das misturas realizada em diferentes intervalos de tempo. O tempo necessário para a remoção da smear layer de amostras de dentina pela solução de EDTAHNa3 a 17% e diferentes concentrações de EDTANa4 isoladas e misturadas com NaOCl foi determinado com o auxílio do microscópio eletrônico de varredura (SEM). A capacidade de dissolução de matéria orgânica pelo NaOCl foi determinada pesando fragmentos de músculo bovino antes e depois da imersão em soluções de 1%, 2,5% e 5% de NaOCl em diferentes períodos de tempo. Além disso, os efeitos do EDTAHNa3, EDTANa4 e HEDP na dissolução de matéria orgânica pelo NaOCl foram avaliados. As alterações produzidas por todas as soluções isoladas e alguns protocolos de irrigação nos componentes orgânicos e inorgânicos da superfície da dentina foram analisadas pela técnica de reflexão total atenuada em espectroscopia no infravermelho por transformação de Fourier (ATRFTIR). Espectros de absorbância foram coletados da superfície da dentina antes e após a imersão das amostras nos irrigantes, e foram calculadas as razões das bandas de amida III/fosfato e carbonato/fosfato. Para quantificar a adesão da CHX à dentina mineralizada e à dentina desmineralizada por diferentes protocolos de irrigação, foram determinadas as áreas da banda associada a CHX com pico em 1492 cm−1 em espectros obtidos por ATR-FTIR. Os efeitos de diferentes protocolos de irrigação na rugosidade e molhabilidade da superfície da dentina foram medidos com um rugosímetro de bancada e a técnica de gota séssil, respectivamente. Para os ensaios de adesão de microrganismos, amostras foram preparadas e tratadas da mesma maneira e com os mesmos protocolos de irrigação utilizados nos testes de rugosidade e molhabilidade. Em seguida, Candida albicans e Enterococcus faecalis foram mantidos em contato com a dentina por 2 horas e as amostras foram analisadas no microscópio confocal de varredura laser (CLSM). Testes de push-out foram realizados para determinar o impacto de diferentes protocolos de irrigação na resistência de união à dentina do cimento AH Plus ao longo do tempo. Canais de dentes incisivos de bovinos foram instrumentados, irrigados e em seguida obturados utilizando apenas o cimento AH Plus. Metade das amostras foi submetida a avaliação de push-out 7 dias após a obturação e a outra metade após 20 meses. Os resultados dos experimentos mostraram que o EDTAHNa3 causou uma perda quase completa e imediata do cloro livre do NaOCl, enquanto o EDTANa4 promoveu um declínio lento e concentração dependente. A smear layer foi removida apenas por soluções descalcificantes e em cerca de 1 min pelo EDTAHNa3 a 17% e em 5 min pelo EDTANa4, tanto isolados ou misturados com o NaOCl. O aumento da concentração de NaOCl e do tempo de contato com os fragmentos de músculo bovino intensificou a dissolução da matéria orgânica. As misturas de NaOCl com EDTANa4 e HEDP foram capazes de dissolver as amostras de músculo ao longo do tempo, no entanto, o EDTAHNa3 afetou fortemente a capacidade de dissolução do NaOCl quando eles foram misturados. Os resultados dos experimentos com ATR-FTIR mostraram que o aumento da concentração do NaOCl intensificou a desproteinização do colágeno da dentina com redução da relação amida III/fosfato. Para o mesmo agente de descalcificação, quanto maior a concentração e o tempo de imersão, maior a remoção de fosfato, exposição da matriz de colágeno e consequentemente o aumento da proporção amida III/fosfato. O PAA causou os maiores aumentos na relação amida III/fosfato, seguido de EDTAHNa3, EDTANa4 e HEDP e esta ordem foi mantida nos protocolos em que o NaOCl foi usado antes dos agentes descalcificantes. O NaOCl necessitou aproximadamente 0,5 min para desproteinizar a matriz de colágeno exposta após a remoção de fosfato pelo EDTAHNa3 e o PAA. A relação carbonato/fosfato diminuiu após 30 s de imersão das amostras em soluções de NaOCl a 1%, 2,5% e 5%, sem mais alterações ao longo do tempo. O carbonato da dentina foi removido mais rápido do que o fosfato por todos os agentes descalcificantes empregados sozinhos e nos protocolos de irrigação em que o uso do NaOCl foi seguido pelo uso do EDTAHNa3, PAA e HEDP. Para os protocolos de irrigação que associam o NaOCl com soluções quelantes, o último irrigante utilizado definiu as proporções finais de amida II/fosfato e carbonato/fosfato da dentina. Para as análises da adesão da CHX em ATR-FTIR, os resultados mostraram que a adsorção deste irrigante à dentina foi potencializada quando agentes quelantes foram utilizados antes da CHX. Em relação aos experimentos de rugosidade da superfície, a solução salina, o NaOCl, o HEDP e a CHX não alteraram a rugosidade da dentina, mas o EDTAHNa3 e o PAA a aumentaram. A molhabilidade da superfície aumentou após o uso de todos os irrigantes, sendo que o HEDP causou os maiores aumentos. Nos ensaios de adesão dos microrganismos, a smear layer e o colágeno exposto pelos agentes quelantes favoreceram a adesão de E. faecalis. A adesão da C. albicans foi maior em superfícies com smear layer ou mais mineral. O uso de CHX como irrigante final reduziu a adesão de ambos os microrganismos. A molhabilidade não influenciou a adesão dos microrganismos, enquanto o aumento da rugosidade parece potencializar a adesão do E. faecalis. Os experimentos de resistência de união do AH Plus à dentina mostraram que a irrigação com NaOCl e a mistura de NaOCl + EDTANa4 produziram valores de resistência de união em 7 dias mais baixos em comparação com NaOCl + EDTAHNa3, NaOCl + EDTAHNa3 + NaOCl, NaOCl + EDTAHNa3 + CHX e a mistura de NaOCl + HEDP. Após 20 meses, os valores mais baixos foram obtidos nos grupos irrigados com NaOCl e NaOCl + EDTAHNa3. Os grupos de NaOCl + EDTAHNa3 + NaOCl, mistura de NaOCl + HEDP e mistura de NaOCl + EDTANa4 apresentaram valores de força de união por push-out em 20 meses semelhante aos valores em 7 dias. Foi possível concluir que as soluções de irrigação testadas neste estudo têm diferentes efeitos na matéria orgânica e inorgânica e elas podem afetar as ações umas das outras quando misturadas. Independentemente de serem utilizadas isoladas ou combinadas em protocolos de irrigação, os irrigantes causam modificações nas propriedades físico-químicas dentinárias que influenciam na adesão do cimento AH Plus a curto e longo prazo e na adesão de microrganismos à superfície em casos de recontaminação.(AU)
Subject(s)
Animals , Cattle , Dentin/drug effects , Dentin/microbiology , Epoxy Resins/chemistry , Root Canal Filling Materials/chemistry , Root Canal Irrigants/chemistry , Candida albicans/drug effects , Chlorhexidine/chemistry , Edetic Acid/chemistry , Etidronic Acid/chemistry , Peracetic Acid/chemistry , Reproducibility of Results , Smear Layer/drug therapy , Sodium Hypochlorite/chemistry , Time FactorsABSTRACT
Osteoporosis, a disease characterized by progressive bone loss, has been the target of several studies in the past few years. It results in a much higher risk for fractures and might cause slower bone lesion healing. The aim of this work was to study the effects of Risedronate (allopathic medicine) and Calcarea phosphorica 6CH (homeopathic medicine) on the repair of bone lesions in male rats with osteoporosis induced by castration. Eighty-four three-month-old rats were used divided into four groups of twenty-one animals each. Three groups where castrated and one group was submitted to Sham surgery. One month later, cortical lesions were made in all animals' tibiae and, after one day, the different experimental treatments began according to the following groups: CR - castrated/Risedronate (1 mg/kg/day); CCp - castrated/Calcarea phosphorica 6CH (3 drops/day); CP - castrated/placebo and SP - Sham/placebo. The animals were sacrificed at seven, fourteen and twenty-eight days after the beginning of the treatments and had their tibiae removed. Digital radiographs of the tibiae were taken and analyzed in order to evaluate the optical density of the defect area. Then, they were decalcified and processed for histological and histomorphometrical analysis. The data were submitted to ANOVA, and to the Tukey and Dunnett tests (5 percent). The allopathic and homeopathic treatments led to different bone formation as regards remodeling and maturation aspects. Further research is necessary to access the resistance and quality of the newly formed bone.
A osteoporose, doença caracterizada pela perda de massa óssea, tem sido alvo de estudos nos últimos anos. Fraturas decorrentes da osteoporose são muito comuns e podem apresentar consolidação mais lenta. O objetivo deste trabalho foi avaliar o efeito do risedronato (medicamento alopático) e da Calcarea phosphorica 6CH (medicamento homeopático) no reparo de lesões ósseas em ratos com osteoporose induzida por castração. Para tanto, foram utilizados oitenta e quatro ratos, com três meses de idade, separados em quatro grupos de vinte e um animais, sendo três grupos submetidos à castração e um grupo a falsa cirurgia ("Sham"). Um mês após a cirurgia, foram realizadas lesões corticais na tíbia de todos os animais e, a partir do dia seguinte, os tratamentos experimentais foram iniciados de acordo com os seguintes grupos: CR - castrado/risedronato (1 mg/kg/dia); CCp - castrado/Calcarea phosphorica 6CH (três gotas/dia); CP - castrado/placebo e SP - "sham"/placebo. Os animais foram sacrificados aos sete, catorze e vinte e oito dias após o início do tratamento e as tíbias foram removidas. Radiografias digitais foram realizadas e avaliadas para obter a densidade óptica na área do defeito. Em seguida, foram descalcificadas e processadas para análise histológica e histomorfométrica. Os dados foram submetidos a ANOVA e aos testes de Tukey e Dunnett (5 por cento). Os tratamentos alopático e homeopático levaram a formação óssea de aspecto diferente considerando a remodelação e maturação. Mais pesquisas são necessárias para avaliar a resistência e qualidade do osso neoformado.
Subject(s)
Animals , Male , Rats , Bone Density Conservation Agents/therapeutic use , Bone Remodeling/drug effects , Calcium Phosphates/therapeutic use , Etidronic Acid/therapeutic use , Osteoporosis/drug therapy , Phytotherapy , Analysis of Variance , Bone Density Conservation Agents/pharmacology , Bone Density/drug effects , Calcium Phosphates/pharmacology , Disease Models, Animal , Etidronic Acid/analogs & derivatives , Orchiectomy , Osteoporosis/pathology , Plant PreparationsABSTRACT
Alertar para o fato de que os bisfosfonatos, importante classe de drogas utilizada no tratamento da osteoporose, podem causar esclerite. Relatamos caso de uma paciente que apresentou episódio de esclerite durante o uso de alendronato e que recidivou com o uso de outra droga da mesma classe, o risedronato, um ano depois. Os bisfosfonatos constituem uma classe de drogas que tem sido, frequentemente, utilizada no tratamento da osteoporose. No entanto, boa parte da classe médica pode não estar alerta para os efeitos colaterais oculares, tendo em vista que não se encontrou relato desses efeitos na literatura nacional. Este trabalho mostra dois episódios de esclerite, ocorridos em uma mesma paciente, com intervalo de, aproximadamente, um ano, possivelmente, provocados pelo uso de dois tipos de bisfosfonatos. Nas duas ocasiões, houve resposta favorável à suspensão da droga, com a utilização de um tratamento pouco agressivo. Esse fato justificou a não realização da pesquisa de doenças consideradas causas de esclerite, das quais a paciente não apresentava sinais, sintomas, assim como qualquer história pregressa. Tudo isso, associado à existência, na literatura internacional, de relatos de casos de inflamação ocular, inclusive de esclerite, relacionados com o uso dos bisfosfonatos, reforça a hipótese de que os episódios, realmente, tenham sido provocados pelo uso da droga.
To alert to the fact that bisphosphonates, important class of drugs used in the treatment of osteoporosis, can cause scleritis. Report of a female patient's case, who presented an episode of scleritis while using alendronate, and who had one year later another episode during the use of a drug from the same class, risedronate. The bisphosphonates are a class of drugs, which have been used very often in the treatment of osteoporosis. However, a great part of the physicians can not be alert for its ocular side effects, considering that in the national literature there's no report of these effects. This article report two episodes of scleritis, occurred to a patient, in a period of one year, probably caused by the use of two types of bisphosphonates. In these two opportunities, there was recovery after the suspension of the drug, associated with a less aggressive treatment. This fact justified not to perform the search for diseases considered to be the cause of scleritis, of which the patient didn't show any sign, symptom or past clinical history. These facts, associated to the existence of some reports of ocular inflammation, including scleritis, associated to the use of bisphosphonates, reinforces the hypothesis that the episodes, in fact, have been caused by the use of the drug.
Subject(s)
Humans , Female , Aged , Alendronate , Etidronic Acid/adverse effects , Eye Infections , Scleritis/complications , Osteitis Deformans , ScleritisABSTRACT
Se realizó un estudio descriptivo, prospectivo, de tipo transversal para determinar el nivel de satisfacción en 101 pacientes con Osteogénesis Imperfecta en el tratamiento con Pamidronato. Se contactaron por encuesta vía telefónica a 52 pacientes quienes contaban con al menos dos ciclos de tratamiento.De 505 fracturas reportadas, el 71% se produjeron previas al tratamiento, evidenciándose disminución del 42% de fracturas. 69 % de los pacientes no refieren dolor posterior al tratamiento en comparación con el 27% que no refieren dolor previo al tratamiento. El porcentaje de pacientes capaces de caminar de manera independiente aumentó 21%, disminuyendo 31% de paciente confinados al lecho o silla de ruedas. El porcentaje de mejoría, conformidad y recomendación del tratamiento es favorable en casi 100% de los entrevistados. El tratamiento con Pamidronato mejora la calidad de vida de los pacientes con Osteogénesis Imperfecta.
We present a descriptive study to evaluate the level of satisfaction in 101 patients with Osteogenesis Imperfecta in treatment with Pamidronato. We contact 52 patient for an enquire by telephone, who have 2 or more ciclos of treatment. From 505 fractures report, the 71% was until treatment, we found disminution of 42% of fractures. 69% of patients dont refer pain after treatment in comparison with the 27% that do not refer pain until treatment. The porcent of patients capables of walk independent increase 21%, decrease 31% of patients that can not walk. The porcent of improvement, conformity and recomendation of treatment is good in also 100% of interview. The treatment with Pamidronato improve the life quality in the patients with Osteogenesis Imperfecta.